2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligands
- 1 July 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 33 (7) , 1919-1924
- https://doi.org/10.1021/jm00169a015
Abstract
The synthesis and receptor-binding profiles at adenosine receptor subtypes for a series of 2-(arylaklyamino)-adenosin-5''-uronamides is described. Halogenated 2-phenethylamino analogues such as a 3e show greater than 200-fold selectivity for the A2 receptor subtype on the basis of rat brain receptor binding. The general structure-activity relationship of this series of compounds is discussed both in terms of potency at A2 receptors as well as receptor subtype selectivity. It is possible to introduce a hydrophilic carboxyalkyl substituent to this series such as in CGS 21680A (3h) and still retain good potency and selectivity for A2 receptors. In addition, functional data in a perfused working rat heart model shows that these compounds possess full agonist properties at A2 receptors with 3 h having a greater than 1500-fold separation between A2 (coronary vosadilatory) and A1 (negative chronotropic) receptor mediated events.This publication has 5 references indexed in Scilit:
- CGS-21680C, AN A2 SELECTIVE ADENOSINE RECEPTOR AGONIST WITH PREFERENTIAL HYPOTENSIVE ACTIVITY1989
- Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers.BMJ, 1986
- CHARACTERIZATION OF THE A2 ADENOSINE RECEPTOR LABELED BY [H-3] NECA IN RAT STRIATAL MEMBRANES1986
- Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissueNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1986
- Effect of pressure development on oxygen consumption by isolated rat heartAmerican Journal of Physiology-Legacy Content, 1967